Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans

Ingibjörg J Gudmundsdóttir; Ian L Megson; Jillian S Kell; Christopher A Ludlam; Keith A A Fox; David J Webb; David E Newby

doi:10.1161/CIRCULATIONAHA.106.638478

Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans

Ingibjörg J Gudmundsdóttir
, Ian L Megson
, Jillian S Kell
, Christopher A Ludlam
, Keith A A Fox
, David J Webb
, David E Newby

Resultado de pesquisa › revisão de pares

31 Citações (Scopus)

Resumo

Protease-activated receptor type 1 (PAR-1) has been proposed as the principal thrombin receptor in humans, although its actions in vivo have not been defined. The aim of the present study was to determine the direct vascular actions of PAR-1 agonism in humans.

Idioma original	English
Páginas (de-até)	1625-32
Número de páginas	8
Revista	Circulation
Volume	114
Número de emissão	15
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.106.638478
Estado da publicação	Published - 2006

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

Acesso ao documento

10.1161/CIRCULATIONAHA.106.638478

Citar isto

@article{c5f2f537d1d94580bf657fae2fc9acc5,

title = "Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans",

abstract = "Protease-activated receptor type 1 (PAR-1) has been proposed as the principal thrombin receptor in humans, although its actions in vivo have not been defined. The aim of the present study was to determine the direct vascular actions of PAR-1 agonism in humans.",

author = "Gudmundsd{\'o}ttir, \{Ingibj{\"o}rg J\} and Megson, \{Ian L\} and Kell, \{Jillian S\} and Ludlam, \{Christopher A\} and Fox, \{Keith A A\} and Webb, \{David J\} and Newby, \{David E\}",

year = "2006",

doi = "10.1161/CIRCULATIONAHA.106.638478",

language = "English",

volume = "114",

pages = "1625--32",

journal = "Circulation",

issn = "1524-4539",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans

AU - Gudmundsdóttir, Ingibjörg J

AU - Megson, Ian L

AU - Kell, Jillian S

AU - Ludlam, Christopher A

AU - Fox, Keith A A

AU - Webb, David J

AU - Newby, David E

PY - 2006

Y1 - 2006

N2 - Protease-activated receptor type 1 (PAR-1) has been proposed as the principal thrombin receptor in humans, although its actions in vivo have not been defined. The aim of the present study was to determine the direct vascular actions of PAR-1 agonism in humans.

AB - Protease-activated receptor type 1 (PAR-1) has been proposed as the principal thrombin receptor in humans, although its actions in vivo have not been defined. The aim of the present study was to determine the direct vascular actions of PAR-1 agonism in humans.

U2 - 10.1161/CIRCULATIONAHA.106.638478

DO - 10.1161/CIRCULATIONAHA.106.638478

M3 - Article

C2 - 17015787

SN - 1524-4539

VL - 114

SP - 1625

EP - 1632

JO - Circulation

JF - Circulation

IS - 15

ER -

Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans

Resumo

ODS da ONU

Acesso ao documento

Impressão digital

Citar isto